Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × Amyloid × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Urinary Bladder Neoplasms 1 Sunburn 1 Stress, Psychological 1 Stress Disorders, Post-Traumatic 1 Prostatic Hyperplasia 1 Motor Activity 1 Melanoma 1 Head and Neck Neoplasms 1 Depression 1 Anxiety Disorders 1 Alzheimer Disease 1

Interventions

Cisplatin 204 Radiotherapy 150 Cetuximab 116 pembrolizumab 96 Fluorouracil 78 Docetaxel 76 Paclitaxel 66 Carboplatin 66 Radiotherapy, Intensity-Modulated 59 Nivolumab 33 Radiation 28 Drug Therapy 26 Gemcitabine 22 Gefitinib 19 Erlotinib Hydrochloride 19 Surgical Procedures, Operative 17 Standard of Care 17 Cyclophosphamide 17 durvalumab 16 Pemetrexed 16 Magnetic Resonance Spectroscopy 16 Surveys and Questionnaires 15 atezolizumab 14 Capecitabine 14 Bevacizumab 14 Low-Level Light Therapy 13 Filgrastim 13 Celecoxib 13 Amifostine 13 Radiosurgery 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡